Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

tandem labs logo

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity
     

Drug Life Cycle Stages:
Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)

Main Service Areas:
Bioanalytical

Services & Capabilities:
LC-MS/MS & Immunoanalytical Services — small & large molecule, discovery, preclinical (GLP), &  clinical studies, and nonproprietary assays; Biomarker Services — discovery and clinical; CLIA and GLP; and multiple platforms; Specialized LC-MS/MS services and specialized immunoanalytical services

Therapeutic Areas:
All therapeutic areas, including those involving high potency and cytotoxic drugs.

James Wilfahrt

Vice president, LabCorp General Manager, Tandem Labs

“The expertise and responsiveness of our staff is directly tied to our ability to meet and exceed the expectations of our pharmaceutical clients. We focus exclusively on bioanalytical services, building strong relationships with clients that allow us to develop programs that meet even the most difficult challenges. We understand that bringing new drugs to market quickly is more challenging than ever in today’s  environment, so we take great pride in doing everything we can to
make your job easier.”